mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.079 |
0.2 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.18 |
0.2 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |